Paul Pearlman, Program Director/Lead for Global Health Technology at NCI, shared on LinkedIn:
“For those attending ASCO 2026, Dr. Fabio Ynoe de Moraes and I will introduce the JCO Global Oncology special series ’10 Years of the National Cancer Institute’s Affordable Cancer Technology Program’ at the JCO Central Lounge on Monday, June 1 from 11AM – 12PM.
More importantly, we will be joined by two authors from the series, who will present on their work.
Olusegun Alatise from the Obafemi Awolowo University will discuss the paper, ‘Point-of-Care Urine Metabolomics Test to Diagnose Colorectal Cancers in Low- and Middle-Income Countries: A Pilot Controlled Trial in Southwestern Nigeria.’
Karen Anderson from the ASU Biodesign Institute will discuss the paper, ‘Diagnostic Translational Considerations for Global Health Settings: Portable Detection of Human Papillomavirus for Cervical Cancer Screening in India.’
I hope many of you are able to join and I look forward to connecting in Chicago.”
Other articles about ASCO on OncoDaily.